<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical management of gallbladder cancer</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical management of gallbladder cancer</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical management of gallbladder cancer</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael G House, MD, FACS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bhoomi Mehrotra, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stanley W Ashley, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kenneth K Tanabe, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sonali M Shah, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H111050694"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Gallbladder cancer is the most common biliary tract malignancy but accounts for only 4000 new cancer cases in the United States each year. Gallbladder cancer is one of the few cancers that are more common in women than men, with an annual incidence of 1.4 per 100,000 population [<a href="#rid1">1</a>]. </p><p>For patients with early-stage disease, surgery alone can provide cure. Unfortunately, fewer than 10 percent of symptomatic patients and only 20 percent of patients diagnosed incidentally with cholecystectomy have early-stage gallbladder cancer. </p><p>The surgical management of gallbladder cancer is reviewed in this topic. Other related topics are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical evaluation and diagnosis of gallbladder cancer – (See  <a class="medical medical_review" href="/z/d/html/2491.html" rel="external">"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management after surgical resection of gallbladder cancer – (See  <a class="medical medical_review" href="/z/d/html/2525.html" rel="external">"Prognosis and adjuvant treatment for localized, resected gallbladder cancer"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Palliative management of advanced-stage gallbladder cancer – (See  <a class="medical medical_review" href="/z/d/html/2499.html" rel="external">"Treatment of advanced, unresectable gallbladder cancer"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of cholangiocarcinoma – (See  <a class="medical medical_review" href="/z/d/html/2467.html" rel="external">"Adjuvant and neoadjuvant therapy for localized cholangiocarcinoma"</a>.)</p><p></p><p class="headingAnchor" id="H738297"><span class="h1">GALLBLADDER ANATOMY AND PHYSIOLOGY</span><span class="headingEndMark"> — </span>The gallbladder is a small, pear-shaped organ that is located inferior to the margin of the right lobe of the liver  (<a class="graphic graphic_figure graphicRef71755" href="/z/d/graphic/71755.html" rel="external">figure 1</a>). </p><p>The gallbladder is divided into distinct segments: the fundus, body, infundibulum, and neck [<a href="#rid2">2</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>The fundus is the expanded end of the gallbladder that projects away from the margin of the liver. It is anatomically associated with the anterior abdominal wall and hepatic flexure of the colon.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The body of the gallbladder is attached to the liver by loose connective tissue superiorly. Inferiorly, the free margin abuts the duodenum and transverse colon. Superiorly, it is anatomically associated with segments IV and V of the liver  (<a class="graphic graphic_figure graphicRef81897" href="/z/d/graphic/81897.html" rel="external">figure 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The neck of the gallbladder extends from the infundibulum to the cystic duct. Some authors use the terms neck and infundibulum synonymously.</p><p></p><p>The cystic duct joins the common bile duct along its course from the liver to the duodenum. The level of the juncture and course of the cystic duct can vary  (<a class="graphic graphic_figure graphicRef69483" href="/z/d/graphic/69483.html" rel="external">figure 3</a>). </p><p>The gallbladder is supplied by the cystic artery, which is a branch of the right hepatic artery. The cystic artery courses along the cystic duct and divides at the neck of the gallbladder into superficial and deep branches, which supply the anterior/inferior and posterior/superior aspects of the gallbladder, respectively. The cystic artery or an accessory cystic artery can arise from the right hepatic, left hepatic, or common hepatic artery  (<a class="graphic graphic_figure graphicRef56280" href="/z/d/graphic/56280.html" rel="external">figure 4</a>). The venous drainage of the gallbladder generally parallels the course of the arteries draining into the cystic vein, which drains into the gallbladder fossa directly into the middle hepatic vein (ie, it does not accompany the cystic artery). </p><p>The sympathetic nerves that supply the gallbladder are derived from the ninth thoracic segment and from the celiac plexus. The phrenic nerve on the right contributes a few somatic fibers.</p><p>The primary function of the gallbladder is the storage of bile, a fluid produced by the liver that aids with the digestion of fat. Bile is released into the duodenum in response to cholecystokinin (CCK), the major hormone responsible for gallbladder contraction and pancreatic enzyme secretion. CCK is produced in discrete endocrine cells that line the mucosa of the small intestine. (See  <a class="medical medical_review" href="/z/d/html/2558.html" rel="external">"Physiology of cholecystokinin"</a>.)</p><p class="headingAnchor" id="H740004"><span class="h2">Lymphatic drainage</span><span class="headingEndMark"> — </span>The lymphatic drainage of the gallbladder is via several pathways and does not always follow a predictable drainage pattern [<a href="#rid3">3-6</a>]. In some cases, lymph nodes associated with gallbladder cancer can first be seen posterior to the pancreas or portal vein [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/z/d/html/2491.html" rel="external">"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis", section on 'TNM staging system'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>The cholecysto-retropancreatic pathway is the principal pathway and drains along the cystic duct (cystic nodes), common bile duct (pericholedochal nodes, station 12b), portal vein (portocaval node, station 12p), and posterior pancreas (superior retropancreatic node, station 13) to the paraaortic region (paraaortic nodes, station 16). In one study, this route was stained in 95 percent of patients [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The cholecysto-celiac pathway, the next most common pathway, drains along the cystic duct (cystic nodes) and medially along the hepatoduodenal ligament (station 12a) superior to the head of the pancreas to the portal vein (station 12), hepatic artery (station 8), and celiac axis (station 9). Among lymph nodes along this route, one study found that the posterior common hepatic node was most frequently stained (45 percent) [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The cholecysto-mesenteric pathway drains to the left in front of the portal vein (station 12) connecting with the nodes at the root of the mesentery (superior mesenteric nodes, station 14).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A hilar route that ascends directly toward the hepatic hilum has been described in an animal model [<a href="#rid6">6</a>]. </p><p></p><p>The cystic duct, common bile duct, hepatic artery, and portal vein lymph nodes are considered locoregional according to the 8<sup>th</sup> edition of the American Joint Committee on Cancer (AJCC) staging manual (2017) [<a href="#rid7">7</a>]. Tumor involvement of the paraaortic, paracaval, superior mesenteric artery, and celiac lymph nodes is considered distant metastasis. Thus, during potentially curative surgery for gallbladder cancer, lymphadenectomy is generally not performed beyond the porta hepatis and hepatoduodenal ligament. (See <a class="local">'Lymph node dissection'</a> below.)</p><p class="headingAnchor" id="H4066975018"><span class="h1">STAGING</span><span class="headingEndMark"> — </span>The American Joint Committee on Cancer (AJCC) Tumor, Node, Metastasis (TNM) staging classification of gallbladder cancer is the preferred classification in the United States, and the latest (8<sup>th</sup>) edition is shown here  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>). Other classification schemes and the distribution of disease by stage are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2491.html" rel="external">"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis", section on 'Staging'</a>.)</p><p>The risk of distant metastases increases as the T stage increases. In one review, peritoneal and/or liver metastases were present in 16, 42, and 79 percent of patients with T2, T3, and T4 disease, respectively [<a href="#rid8">8</a>]. </p><p>Lymphatic metastases are found in 35 to 80 percent of patients with ≥T2 disease at diagnosis [<a href="#rid9">9-13</a>]. Locoregional nodes, including those along the cystic duct, common bile duct, hepatic duct, and/or portal vein, can be removed by a lymph node dissection with or without excision of the extrahepatic bile duct. However, involvement of paraaortic, paracaval, superior mesenteric artery, and/or celiac artery nodes is considered distant metastatic disease and incurable with surgery, even with a lymph node dissection. </p><p>Due to advanced disease, only 15 to 60 percent of patients with gallbladder cancer are candidates for resection at time of diagnosis [<a href="#rid14">14,15</a>]. Thus, staging prior to considering resection is important and can be accomplished using a combination of cross-sectional imaging and diagnostic laparoscopy. (See <a class="local">'Evaluation for resectability and staging'</a> below.)</p><p class="headingAnchor" id="H107468612"><span class="h1">GALLBLADDER CANCER DIAGNOSED BEFORE SURGERY</span><span class="headingEndMark"> — </span>Gallbladder cancer may be diagnosed preoperatively, intraoperatively at the time of surgical exploration for abdominal symptoms attributed to another disease process, or postoperatively upon examination of the gallbladder specimen, typically removed for symptomatic cholelithiasis. In contemporary series, only approximately 50 percent of gallbladder cancers are recognized before surgery [<a href="#rid16">16,17</a>]. </p><p>Patients with right upper abdominal pain, and particularly those with<strong> jaundice</strong> or signs of duodenal obstruction, are more likely to have locally advanced disease and to be identified preoperatively. Unfortunately, only 10 to 25 percent of such patients are amenable to a curative resection [<a href="#rid8">8,16</a>]. As such, patients diagnosed or suspected of having gallbladder cancer must undergo an evaluation to determine if radical abdominal surgery is warranted  (<a class="graphic graphic_algorithm graphicRef116505" href="/z/d/graphic/116505.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H3025499568"><span class="h2">Evaluation for resectability and staging</span><span class="headingEndMark"> — </span>The minimal staging evaluation of patients with suspected or proven gallbladder cancer includes cross-sectional imaging and diagnostic laparoscopy [<a href="#rid18">18</a>]. </p><p class="headingAnchor" id="H3210360685"><span class="h3">Cross-sectional imaging</span><span class="headingEndMark"> — </span>For patients who present with an ultrasound-detected gallbladder mass, we recommend:</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal computed tomography (CT) with dual-phase contrast to rule out involved extraregional lymph nodes, vascular invasion, liver spread (direct extension or metastases), or peritoneal implants  (<a class="graphic graphic_diagnosticimage graphicRef129033" href="/z/d/graphic/129033.html" rel="external">image 1</a>). Multiphase CT also allows for accurate assessment of tumor extent and direct involvement of the hepatic arteries, portal veins, and adjacent organs (duodenum, colon, bile ducts).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal magnetic resonance imaging (MRI) with contrast to evaluate the liver parenchyma and bile duct. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chest CT with or without contrast to rule out distant metastasis to the lung or pleura.</p><p></p><p>The routine use of integrated fluorodeoxyglucose positron emission tomography (PET)/CT scan for staging is controversial, but it may be considered when CT/MRI findings are equivocal for distant sites of metastases or lymphadenopathy beyond the portal area [<a href="#rid19">19</a>]. </p><p>The sensitivity of these modalities in the diagnosis and staging of gallbladder cancer is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2491.html" rel="external">"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis", section on 'Diagnostic evaluation'</a>.)</p><p class="headingAnchor" id="H1673224003"><span class="h3">Staging laparoscopy</span><span class="headingEndMark"> — </span>Gallbladder cancer frequently involves regional lymph nodes or extends directly to adjacent structures such as the liver, bile ducts, stomach, duodenum, pancreas, colon, omentum, or abdominal wall. Such findings may preclude curative resection but may not be detectable by preoperative imaging studies such as CT or MRI. </p><p>Diagnostic staging laparoscopy frequently identifies metastatic disease or other findings that contraindicate tumor resection [<a href="#rid15">15,20-23</a>]. As an example, in a large prospective study of 409 patients undergoing staging laparoscopy for gallbladder cancer, 23 percent of patients had disseminated disease (liver surface disease or peritoneal deposits) [<a href="#rid15">15</a>]. Based on the high incidence of positive findings, staging laparoscopy is recommended prior to laparotomy for all suspected or proven gallbladder cancers &gt;pT1b. </p><p>If available, laparoscopic ultrasound should be employed as an adjunctive imaging method at the time of staging laparoscopy to look for satellite lesions in the liver and define the location of the gallbladder tumor, the relationship of the tumor to surrounding blood vessels, and the likelihood of attaining an adequate margin of liver [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/15106.html" rel="external">"Diagnostic staging laparoscopy for digestive system cancers", section on 'Laparoscopic ultrasound'</a>.)</p><p>The general principles of diagnostic staging laparoscopy for digestive malignancies are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15106.html" rel="external">"Diagnostic staging laparoscopy for digestive system cancers"</a>.)</p><p class="headingAnchor" id="H3980476280"><span class="h2">Unresectable disease</span></p><p class="headingAnchor" id="H1890533942"><span class="h3">Absolute contraindications to resection</span></p><p class="bulletIndent1"><span class="glyph">●</span>Liver metastases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peritoneal metastases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malignant ascites.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tumor involvement of paraaortic, paracaval, superior mesenteric artery, and/or celiac artery lymph nodes. Such involvement is considered distant rather than locoregional metastatic disease and therefore incurable [<a href="#rid7">7</a>]. (See <a class="local">'Staging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extensive involvement of the hepatoduodenal ligament by tumor either directly or through lymph node involvement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Encasement or occlusion of major vessels (eg, common hepatic artery or main portal vein) by tumor.</p><p></p><p>Direct involvement of the colon, duodenum, or liver does not represent an absolute contraindication. Given that the majority of patients with gallbladder cancer who present with preoperative jaundice will have disseminated disease, such patients should undergo multidisciplinary evaluation before surgery is offered [<a href="#rid25">25,26</a>]. </p><p class="headingAnchor" id="H1414193093"><span class="h3">Relative contraindications to resection</span></p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative jaundice is considered a relative contraindication to radical resection of <strong>fundus-based</strong> gallbladder cancer [<a href="#rid18">18</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perihilar-type</strong> gallbladder cancer arising from the infundibulum or cystic duct typically presents with jaundice. In this situation, jaundice should not be considered a contraindication to operative resection. </p><p></p><p>Overall survival was shorter among patients who presented with jaundice (hazard ratio [HR] 2.21, 95% CI 1.64-2.97); patients with jaundice were less likely to have resectable disease due to extensive tumor involvement of the hepatoduodenal ligament (odds ratio 0.27, 95% CI 0.17-0.43), and jaundiced patients had higher odds of postoperative morbidity, bile leak, and postoperative liver failure versus nonjaundiced controls [<a href="#rid27">27</a>]. In at least one series, the few patients who underwent surgery because they appeared to have potentially resectable disease by radiographic staging had a median length of disease-free survival of only six months, and there were no disease-free survivors at two years [<a href="#rid28">28</a>]. </p><p class="headingAnchor" id="H2955578656"><span class="h3">Treatment for unresectable disease</span><span class="headingEndMark"> — </span>Patients found to have contraindications to resection based upon preoperative imaging, laparoscopic staging, or intraoperative exploration because of major encasement of vascular structures should be referred for chemotherapy. There is no role for a palliative noncurative radical surgery, for the purpose of debulking. </p><p>Some patients with locally advanced but nonmetastatic gallbladder cancer may be rendered potentially resectable after initial chemotherapy or chemoradiotherapy, but the frequency with which this occurs is low. Few data are available on long-term outcomes after neoadjuvant chemotherapy for gallbladder cancer. A systematic review concluded that there was insufficient evidence to support the routine use of neoadjuvant therapy in advanced gallbladder cancer [<a href="#rid29">29</a>]. Importantly, subsequent attempts at resection following neoadjuvant therapy should be undertaken only if it is possible to achieve a complete, potentially curative resection. This subject is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2499.html" rel="external">"Treatment of advanced, unresectable gallbladder cancer", section on 'Local treatment for locally advanced non-metastatic disease'</a>.)</p><p class="headingAnchor" id="H985515173"><span class="h2">Resectable disease</span><span class="headingEndMark"> — </span>Once peritoneal metastatic disease and other absolute contraindications to attempted resection have been ruled out with cross-sectional imaging and diagnostic laparoscopy, the surgeon can proceed with resection. Surgery is the only potentially curative therapy for gallbladder cancer [<a href="#rid30">30,31</a>]. </p><p>Surgical treatment of gallbladder cancer involves removal of the gallbladder (cholecystectomy) typically with a rim of liver tissue (extended cholecystectomy), except in T1a disease, and may include bile duct resection, lymph node resection, more extensive liver resection, or resection of involved adjacent organs, depending upon the Tumor, Node, Metastasis (TNM) stage of the tumor  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>) [<a href="#rid32">32</a>]. General surgical approaches by tumor stages are presented here; technical details are discussed in the subsequent sections. (See <a class="local">'Resection techniques'</a> below.)</p><p class="headingAnchor" id="H1665204462"><span class="h3">Early T stage diseases</span><span class="headingEndMark"> — </span>Gallbladder cancers that are confined to the wall of the gallbladder (ie, stage 0, I, or II; Tis, T1, or T2  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>)) are potentially resectable with curative intent. For patients with a gallbladder cancer that extends beyond the mucosa (ie, &gt;T1a), some but not all studies link better outcomes with more radical surgery [<a href="#rid11">11,30,33-42</a>]. However, randomized trials comparing simple cholecystectomy with radical surgery for gallbladder cancer have not been performed; all available studies are retrospective reports. </p><p class="headingAnchor" id="H3037296014"><span class="h4">T1a</span><span class="headingEndMark"> — </span>Simple cholecystectomy alone is felt to be adequate for patients with tumors that are limited to the lamina propria (T1a). Cure rates following simple cholecystectomy range from 73 to 100 percent in case series [<a href="#rid43">43-48</a>]. (See <a class="local">'Simple cholecystectomy'</a> below.)</p><p class="headingAnchor" id="H2348752441"><span class="h4">T1b</span><span class="headingEndMark"> — </span>Patients with stage T1b disease benefit from a more radical approach, given that T1b tumors are associated with a higher incidence of lymph node metastases compared with T1a tumors (15 versus 2.5 percent) [<a href="#rid33">33,34,44,45,47,49</a>]. Some investigators have shown a median survival advantage of over three years for extended versus simple cholecystectomy for T1b cancers (9.85 versus 6.42 years, respectively) [<a href="#rid50">50</a>]. Thus, extended cholecystectomy (cholecystectomy including adjacent liver tissue from segments IVb and V) should be performed for medically fit patients who have tumors that invade the muscular layer (T1b). And yet, a retrospective study of 464 patients from the National Cancer Database (2004 to 2012) showed that fewer than 50 percent of patients with T1b gallbladder cancer received extended cholecystectomy, and among those who did, 15 percent had positive lymph nodes [<a href="#rid51">51</a>]. Failure to perform extended cholecystectomy risks incomplete staging and thus undertreatment (omission of adjuvant chemotherapy) of those with T1b gallbladder cancer. (See <a class="local">'Extended cholecystectomy'</a> below.)</p><p class="headingAnchor" id="H80341952"><span class="h4">T2</span><span class="headingEndMark"> — </span>Extended cholecystectomy should also be performed in patients with a T2 tumor [<a href="#rid52">52,53</a>]. T2 tumors invade the perimuscular connective tissue without involvement of the serosa. In the 8<sup>th</sup> edition of the American Joint Committee on Cancer (AJCC) TNM staging manual (2017)  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>), T2 gallbladder cancers are subdivided into T2a (peritoneal) and T2b (hepatic) depending on the invasion site. T2b disease generally has worse prognosis than T2a disease. Some authors have suggested that extended cholecystectomy should be mandated in patients with T2b (hepatic) but not T2a (peritoneal) disease based on survival benefit [<a href="#rid54">54</a>]. This approach, however, is not universally accepted, and the standard of care remains extended cholecystectomy for <strong>all</strong> resectable T2 disease [<a href="#rid55">55</a>]. </p><p>The need to perform a more aggressive resection is supported by the high rate of residual disease discovered on reresection for T2 disease discovered incidentally. In a retrospective study of six major hepatobiliary centers, upon reresection of T2 tumors found incidentally, residual disease was found in 57 percent of the patients at any site; lymph nodes were involved in 31 percent, and the liver was involved in 10 percent [<a href="#rid56">56</a>]. Lymph node metastases have been seen in up to 62 percent of patients with T2 disease [<a href="#rid57">57</a>]. Given the high rate of residual disease seen after reresection of T2 disease, it is not surprising that high rates of positive margins (11 out of 25 in one study [<a href="#rid48">48</a>]) and high rates of local recurrence (40 percent) are found in patients with T2 disease treated with simple cholecystectomy alone [<a href="#rid58">58</a>]. </p><p>Whether T2 gallbladder cancer should be resected with a segmental resection of segments IVb and V or a wedge resection is debated [<a href="#rid59">59,60</a>]. A propensity score-matched retrospective study associated segmental resection with improved disease-free survival (hazard ratio 0.708, 95% CI 0.51-0.99), but not overall survival, compared with wedge resection [<a href="#rid61">61</a>]. However, patients undergoing segmental resection incurred more complications (29 versus 9 percent) and a longer hospital stay (17 versus 19 days). </p><p class="headingAnchor" id="H766658976"><span class="h3">Locally advanced or node-positive diseases</span><span class="headingEndMark"> — </span>In the past, surgeons were reluctant to operate on patients with locally advanced (T3/4) gallbladder cancer because of an overall poor prognosis. Although some series document poor survival even with extended resection [<a href="#rid62">62</a>], support for radical surgery in patients with T3 and even T4 disease has increased with the publication of retrospective reports indicating long-term survival in 15 to 63 percent and 7 to 25 percent of patients, respectively [<a href="#rid8">8,11,33,34,44,63-68</a>].</p><p>Some groups advocate even more extensive resection involving hepatectomy, pancreaticoduodenectomy, colectomy, and even nephrectomy for patients with higher T stage but potentially resectable disease. A median survival time of 17 months with a 2 percent mortality rate has been reported [<a href="#rid35">35</a>]. Although long-term survivors are reported, morbidity and mortality rates are high (48 to 54 percent and 15 to 18 percent, respectively). A study of 79 major hepatectomies alone and 38 major hepatectomies combined with pancreaticoduodenectomy found longer survival associated with the former (32 versus 10 months) and higher morbidities and mortalities associated with the latter [<a href="#rid69">69</a>]. </p><p class="headingAnchor" id="H2670042497"><span class="h4">T3</span><span class="headingEndMark"> — </span>T3 tumors invade through the serosa of the gallbladder and directly invade the liver and/or one other adjacent organ that normally contacts the gallbladder (eg, stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile duct). For T3 tumors, an extended cholecystectomy en bloc with the involved adjacent organ may be performed but has not been associated with improved survival in Western reports [<a href="#rid38">38</a>]. Thus, radical surgery such as major hepatic resection is appropriate to clear disease when necessary but not mandatory in all cases. (See <a class="local">'Hepatic resection'</a> below.)</p><p class="headingAnchor" id="H1324708651"><span class="h4">T4</span><span class="headingEndMark"> — </span>T4 tumors are generally locally unresectable due to vascular invasion of the main portal vein or hepatic artery or involvement of multiple adjacent extrahepatic organs or structures. Curative resection may be possible in selected patients with stage IVa disease (T4, N0-1, M0), though this approach is most commonly futile given the frequent coexistence of metastatic disease. N2 or M1 diseases are distant metastasis and not curable. (See <a class="local">'Unresectable disease'</a> above.)</p><p class="headingAnchor" id="H2332009788"><span class="h4">Node-positive</span><span class="headingEndMark"> — </span>For patients with tumor involvement of locoregional lymph nodes (cystic duct, common bile duct, hepatic artery, or portal, and portal vein), five-year survival rates from 28 to 60 percent are reported with radical resection [<a href="#rid44">44,64,70</a>]. </p><p>Results with radical lymphadenectomy are less favorable if the extent of nodal disease is beyond that of the hepatoduodenal ligament, posterosuperior pancreaticoduodenal area, and along the common hepatic artery [<a href="#rid34">34,70</a>]. If preoperative fine needle aspiration confirms involvement of a lymph node beyond the locoregional nodes, the patient is not curable; thus, surgery should be performed only for palliation of specific problems. (See <a class="local">'Unresectable disease'</a> above and <a class="local">'Palliative procedures'</a> below.)</p><p class="headingAnchor" id="H205610933"><span class="h1">GALLBLADDER CANCER DIAGNOSED DURING GALLBLADDER SURGERY</span><span class="headingEndMark"> — </span>Patients with early, invasive, potentially curable gallbladder cancer are often asymptomatic or may have nonspecific symptoms that mimic or are due to cholelithiasis or cholecystitis. Because the symptoms are nonspecific, gallbladder cancer may not be suspected preoperatively. Gallbladder cancer may be identified or strongly suspected at surgical exploration [<a href="#rid15">15,16</a>]. Therefore, it is important to have a plan for identifying and managing gallbladder cancer during the course of a routine laparoscopic or open cholecystectomy [<a href="#rid16">16</a>]. </p><p>The surgeon should maintain a high index of suspicion for gallbladder cancer in patients with risk factors such as calcified (porcelain) gallbladder, gallbladder polyps, congenital biliary cysts, anomalous pancreaticobiliary junction, or longstanding chronic infection. A risk-score model has been proposed to predict incidental gallbladder cancer based on age, sex, previous cholecystitis, and either jaundice or acute cholecystitis [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/z/d/html/2491.html" rel="external">"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis", section on 'Risk factors'</a> and  <a class="medical medical_review" href="/z/d/html/643.html" rel="external">"Porcelain gallbladder"</a>.) </p><p>If an obviously malignant lesion is encountered intraoperatively during laparoscopic cholecystectomy, it is best <strong>not</strong> to sample the lesion laparoscopically, to reduce the hazard of peritoneal seeding. Intraoperative options for managing a suspected gallbladder cancer depend upon the experience of the operating surgeon with complex hepatobiliary surgery.</p><p class="headingAnchor" id="H345601243"><span class="h2">Surgeons experienced in hepatobiliary surgery</span><span class="headingEndMark"> — </span>If the surgeon is experienced in complex hepatobiliary surgery, the cholecystectomy should proceed as usual, and the specimen should be sent for a frozen section of the suspicious area of the gallbladder. If the frozen section is positive for malignancy, the procedure should be converted to open, and an extended cholecystectomy is carried out. The indications for performing extrahepatic bile duct resection or lymph dissection are the same as for other gallbladder cancer surgeries. (See <a class="local">'Bile duct resection'</a> below and <a class="local">'Lymph node dissection'</a> below.)</p><p class="headingAnchor" id="H4012540556"><span class="h2">Surgeons inexperienced in hepatobiliary surgery</span><span class="headingEndMark"> — </span>For surgeons who are unfamiliar with complex hepatobiliary surgery, closing the incisions with or without simple cholecystectomy and referral to a more experienced surgeon or center is appropriate. In a small retrospective review, no significant differences in survival were found comparing six patients who underwent immediate open conversion and radical resection with 33 patients who were referred to another center for resection [<a href="#rid20">20</a>]. Patients will undergo further evaluation and treatment as outlined in the next section. (See <a class="local">'Gallbladder cancer diagnosed after gallbladder surgery'</a> below.)</p><p class="headingAnchor" id="H1544566861"><span class="h1">GALLBLADDER CANCER DIAGNOSED AFTER GALLBLADDER SURGERY</span><span class="headingEndMark"> — </span>A common scenario leading to a diagnosis of gallbladder cancer is the return of a final pathology report indicating gallbladder cancer in a resected gallbladder specimen [<a href="#rid20">20,72,73</a>]. Incidental gallbladder cancer is found in 0.25 to 1.5 percent of patients undergoing laparoscopic cholecystectomy [<a href="#rid16">16,20,43,72,74-80</a>]. In patients undergoing cholecystectomy for cholelithiasis, unsuspected gallbladder cancer may be diagnosed based upon intraoperative findings or the final pathologic analysis. In three large series combined, incidental gallbladder cancer was found in 31 of 9497 patients undergoing laparoscopic cholecystectomy (0.33 percent) [<a href="#rid43">43,72,76</a>]. </p><p>Patients who are diagnosed with gallbladder cancer previously unsuspected at the time of cholecystectomy should undergo staging evaluation with cross-sectional imaging as described above (see <a class="local">'Cross-sectional imaging'</a> above). As with patients with gallbladder cancer that is diagnosed preoperatively, the management of incidental gallbladder cancer depends upon disease extent (T stage)  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>). If the T stage of the resected, incidental gallbladder cancer is T1b, T2, or T3, we recommend surgical re-exploration and reresection  (<a class="graphic graphic_algorithm graphicRef116506" href="/z/d/graphic/116506.html" rel="external">algorithm 2</a>), ideally within two months of the initial surgery.</p><p>The rationale is based on the observation that patients with T1b, T2, or T3 disease for whom a diagnosis of gallbladder cancer is made incidentally on postoperative gallbladder pathology have a high rate of residual disease, and those who undergo reresection have better survival than those who do not [<a href="#rid8">8,9,20,56,81-84</a>]. </p><p>Investigators have developed models to better predict locoregional residual and distant disease in patients with incidentally diagnosed gallbladder cancer based on T stage, tumor grade, and additional information from pathology (eg, lymphovascular or perineural invasion) [<a href="#rid85">85,86</a>]; one such model is outlined in the table  (<a class="graphic graphic_table graphicRef116061" href="/z/d/graphic/116061.html" rel="external">table 2</a>). However, independent validation of models such as these is needed before they can be considered for clinical use. </p><p>Although reresection is associated with additional risk, improvements in perioperative care and operative technique have decreased perioperative morbidity and mortality associated with major liver surgery in high-volume centers [<a href="#rid24">24,87</a>]. Prior to performing reresection, patients should be staged with cross-sectional imaging. A staging laparoscopy may be performed to rule out peritoneal metastases, especially in those with T3 disease, poorly differentiated histology, or positive margins [<a href="#rid22">22</a>]. However, staging laparoscopy is of less value in these cases, given the absence of peritoneal metastases at the recent laparoscopic cholecystectomy. (See <a class="local">'Evaluation for resectability and staging'</a> above.) </p><p>The optimal timing of the reoperation is not clear. In a retrospective study, those who underwent reoperations between four and eight weeks from the date of the original cholecystectomy had better overall survival (median 40.4, 95% CI 16.4 to 64.4 months) than those who underwent reoperations either before four weeks (median 17.4, 95% CI 11.1 to 23.7 months) or after eight weeks (median 22.4, 95% CI 18.2 to 26.6 months) [<a href="#rid88">88</a>]. However, these data are retrospective, and the timing of reoperation is often influenced by nonclinical factors such as patient access to a qualified surgeon or center. </p><p class="headingAnchor" id="H2246608007"><span class="h2">T1a</span><span class="headingEndMark"> — </span>Patients found to have incidental T1a tumors with negative margins are generally felt to be cured by the cholecystectomy that has already been performed [<a href="#rid24">24,47,89-93</a>]. Reresection for T1a tumors does not appear to provide an overall survival benefit [<a href="#rid52">52,81,94,95</a>]. </p><p>The National Comprehensive Cancer Network (NCCN) guidelines recommend that these patients be observed without specifying details; we perform cross-sectional imaging at diagnosis and again in six to 12 months. </p><p class="headingAnchor" id="H3614457451"><span class="h2">T1b</span><span class="headingEndMark"> — </span>The optimal approach to incidental T1b disease is more controversial. If there is no contraindication to surgery, extended resection is reasonable for T1b gallbladder cancer. At least two retrospective studies comparing cholecystectomy alone versus extended cholecystectomy for T1b tumors found no significant difference in overall survival (with up to 87 percent 10<strong> </strong>year survival), while other studies have reported improved survival with reresection [<a href="#rid96">96</a>]. </p><p>A number of studies describe high rates of residual disease upon reresection, with lymph node metastases in 12 to 20 percent and liver involvement in up to 13 percent [<a href="#rid12">12,56</a>]. Furthermore, two reports described up to a 50 to 60 percent locoregional recurrence rate after cholecystectomy alone for T1b disease [<a href="#rid97">97</a>]. The authors of both reports concluded that gallbladder cancer is a locally aggressive disease and even early-stage disease warrants extended resection. Finally, as noted above, decision analysis showed a median survival advantage of over three years for extended versus simple cholecystectomy (9.85 versus 6.42 years) [<a href="#rid50">50</a>]. </p><p class="headingAnchor" id="H3405006707"><span class="h2">T2</span><span class="headingEndMark"> — </span>For patients with an incidentally detected T2 tumor on histologic review of the cholecystectomy specimen, re-exploration and extended cholecystectomy are also indicated. Re-exploration identifies residual tumor in 40 to 76 percent of cases [<a href="#rid9">9,11,16,44,45</a>], a high likelihood of liver involvement [<a href="#rid63">63,98</a>], and nodal metastases with T2 disease. Reresection significantly increases the likelihood of long-term disease-free survival in patients with T2 disease. In many series, five-year survival rates increased from 24 to 40 percent to 80 to 100 percent with aggressive surgery [<a href="#rid8">8,9,11,33,34,44,45,48,99-104</a>]. </p><p>As an example, in an analysis of 3209 patients with early-stage gallbladder cancer (12 percent Tis, 30 percent T1, 58 percent T2) derived from the Surveillance, Epidemiology, and End Results (SEER) database, extended resection with lymph node excision was associated with increased survival compared with cholecystectomy alone [<a href="#rid105">105</a>]. However, a significant survival advantage for extended resection was seen only in patients with<sup> </sup>T2 lesions (hazard ratio [HR] 0.49, 95% CI 0.35-0.68). Lymph node excision was also associated with improved survival in patients with T2 lesions in a way that is related to the number of lymph nodes removed (HR 0.42, 95% CI 0.33-0.53 for one to four<sup> </sup>lymph nodes excised; HR 0.26, 95% CI 0.16-0.42 for five or more lymph nodes excised). Based upon these survival differences, one report suggests that for gallbladder cancer to be considered truly node negative, at least six lymph nodes should have been removed [<a href="#rid106">106</a>]. (See <a class="local">'Lymph node dissection'</a> below.)</p><p class="headingAnchor" id="H2351525634"><span class="h2">T3</span><span class="headingEndMark"> — </span>Patients with T3 gallbladder cancer have very high rates of residual disease at re-exploration. In a retrospective study of 115 patients with incidentally discovered gallbladder cancer, 77 percent with T3 disease who underwent reresection had residual disease found in any site, 46 percent had lymph node metastases, and 36 percent had disease involvement in the liver bed [<a href="#rid56">56</a>]. Thus, patients with T3 tumors clearly warrant aggressive reresection. </p><p>In a retrospective study of 463 patients with incidental gallbladder cancer, 24 percent underwent reresection [<a href="#rid104">104</a>]. The median overall survival of reresected and unresected T3 disease was 23 and 12 months, respectively. </p><p>By definition, T4 disease should be clinically apparent at the initial gallbladder surgery and therefore should not be "incidentally" found on gallbladder pathology.</p><p class="headingAnchor" id="H1159123618"><span class="h1">RESECTION TECHNIQUES</span><span class="headingEndMark"> — </span>Surgical treatment of gallbladder cancer involves removal of the gallbladder with a margin of liver (except in T1a disease) with or without regional lymph node or common bile duct resection. If frozen section analysis of the cystic duct stump is negative, a regional lymph node dissection is performed; if it is positive, then regional lymphadenectomy is undertaken along with extrahepatic bile duct resection. Resection of adherent involved adjacent organs may be necessary [<a href="#rid30">30</a>]. </p><p>The optimal surgical approaches for patients diagnosed before, during, and after surgery have been discussed in the preceding sections. The surgical techniques used to resect gallbladder cancer are the focus of this section. </p><p class="headingAnchor" id="H966975"><span class="h2">Simple cholecystectomy</span><span class="headingEndMark"> — </span>Gallbladder removal is a common and generally straightforward operation. Techniques for simple cholecystectomy (open or laparoscopic) are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15096.html" rel="external">"Open cholecystectomy"</a> and  <a class="medical medical_review" href="/z/d/html/3685.html" rel="external">"Laparoscopic cholecystectomy"</a>.)</p><p>Very early stage (Tis, T1a  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>)) gallbladder cancers are cured with simple cholecystectomy alone (see <a class="local">'T1a'</a> above). Simple cholecystectomy may also be indicated in patients with more advanced disease as a palliative procedure to prevent future episodes of cholecystitis, although the value of this approach has not been definitely proven. (See <a class="local">'Palliative procedures'</a> below.)</p><p class="headingAnchor" id="H966253"><span class="h2">Extended cholecystectomy</span><span class="headingEndMark"> — </span>Extended cholecystectomy involves en bloc removal of the gallbladder with a rim of liver of at least 2 cm adjacent to the gallbladder bed. A formal central liver resection (segments IVb and V  (<a class="graphic graphic_figure graphicRef52260" href="/z/d/graphic/52260.html" rel="external">figure 5</a>)) may be appropriate depending upon the location of the tumor (fundus, body, neck). </p><p>An open rather than minimally invasive procedure generally has been recommended [<a href="#rid107">107-111</a>], although data from Hepato-Pancreato-Biliary specialized centers suggest the feasibility of a planned laparoscopic or robotic approach for an early-stage (T1b or T2) gallbladder cancer, the only group for which the risk of nodal metastases is sufficiently low that more radical resection can be avoided [<a href="#rid112">112,113</a>]. However, preoperative staging is not entirely reliable at identifying patients with T1a disease, and improperly staged tumors are at risk for inadequate resection and subsequent recurrence regardless of the operative technique [<a href="#rid15">15</a>]. </p><p>Open gallbladder surgery is usually performed through a right subcostal incision. Additional exposure can be obtained with extension to the upper midline or to the left subcostal region as a chevron incision. (See  <a class="medical medical_review" href="/z/d/html/15096.html" rel="external">"Open cholecystectomy", section on 'Incision'</a>.)</p><p>Once the abdomen is entered and retractors are placed, the margin of liver to be resected can be scored superficially (around the gallbladder and gallbladder mass) with electrocautery to a depth of a couple of millimeters, or sutures can be placed at each side of the margin of resection with absorbable sutures on a blunt needle to mark the margin of resection. The gallbladder, tumor, and margin of liver are resected as a single en bloc specimen. Most studies demonstrate the importance of achieving negative margins (R0 resection) [<a href="#rid12">12,56,63,114-116</a>]. Intraoperative bile spillage should be avoided to minimize risk of cancer cell dissemination. Standard techniques for liver resection are used with bleeding minimized by lowering central venous pressure during liver dissection and the use of surgical hemostatic devices. (See  <a class="medical medical_review" href="/z/d/html/88319.html" rel="external">"Open hepatic resection techniques", section on 'Specific resections'</a>.)</p><p class="bulletIndent1">The cystic duct and cystic artery are identified by gentle retraction on the infundibulum of the gallbladder, and once it is clearly identified and dissected, each is ligated and divided. A sample of the cystic duct margin should be sent for frozen section [<a href="#rid56">56</a>]. If the cystic duct margin is negative, portal lymphadenectomy should be performed. If the cystic duct margin is positive, bile duct resection (including portal and hepatoduodenal lymphadenectomy) and reconstruction are performed. Additional frozen sections will decide the need for further resection. Intraoperative frozen sections can reliably indicate whether tumor is present, but they cannot reliably predict the depth of tumor invasion (T stage of the tumor) [<a href="#rid117">117</a>]. (See <a class="local">'Lymph node dissection'</a> below and <a class="local">'Bile duct resection'</a> below.) </p><p></p><p>At specialized centers, laparoscopic and robotic reresection has been carried out for incidental gallbladder cancer with oncologic outcomes comparable to those of open reresection [<a href="#rid118">118</a>]. However, these studies are observational and small [<a href="#rid119">119</a>].</p><p class="headingAnchor" id="H604313386"><span class="h2">Bile duct resection</span><span class="headingEndMark"> — </span>When gross tumor extends into the common bile duct, or a negative cystic duct margin (as determined by frozen section) cannot be obtained, extrahepatic bile duct resection should be performed [<a href="#rid8">8,13,30,63,120</a>]. In a study of 115 patients who underwent surgery for gallbladder cancer, 42 percent of patients had residual disease in the common bile duct when the cystic duct stump had a positive margin on frozen section [<a href="#rid56">56</a>]. Once a negative common hepatic duct margin is confirmed by frozen section, reconstruction is carried out with a Roux-en-Y hepaticojejunostomy  (<a class="graphic graphic_figure graphicRef67421" href="/z/d/graphic/67421.html" rel="external">figure 6</a>). </p><p>Some have advocated routine resection of the extrahepatic bile ducts, regardless of the result of the cystic duct stump frozen section, as a means for achieving a more complete lymphadenectomy [<a href="#rid121">121</a>]. However, several retrospective series have not shown a survival benefit for this approach in the management of gallbladder cancer [<a href="#rid20">20,56,122,123</a>]. Opponents of routine bile duct resection also cite the risk of potential serious complications of hepaticojejunostomy, such as bile leak and anastomotic stricture [<a href="#rid39">39,122</a>]. Further supporting this view, a retrospective study found that common bile duct resection did not yield a greater lymph node count [<a href="#rid56">56</a>]. </p><p>Although the bile ducts do not need to be resected when the cystic duct margin is negative, the ducts may be compromised during skeletonization of the porta hepatis. If the ducts appear ischemic or otherwise injured, resection and reconstruction will become necessary. </p><p>Techniques of bile duction resection and reconstruction are discussed in another topic. (See  <a class="medical medical_review" href="/z/d/html/15167.html" rel="external">"Bile duct resection and reconstruction"</a>.)</p><p class="headingAnchor" id="H604312644"><span class="h2">Lymph node dissection</span><span class="headingEndMark"> — </span>Lymph node dissection is indicated whether or not bile duct resection is performed if the gallbladder cancer is &gt;T1a. In many cases, lymph node involvement is not obvious intraoperatively, and thus, even normal-appearing nodes should be removed. Lymphatic metastases are found in 35 to 80 percent of patients with gallbladder tumors that invade the perimuscular connective tissue (≥T2) [<a href="#rid2">2,9-13,36,124</a>] and are one of the most reliable predictors of a poor outcome after surgery (five-year survival of 57 percent without versus 12 percent with lymph node metastases) [<a href="#rid125">125</a>]. </p><p>A proper regional lymph node dissection for gallbladder cancer involves removing all lymph nodes in the porta hepatis and along the hepatoduodenal ligaments, including those of the cystic duct, common bile duct, hepatic artery, and portal vein. </p><p>The 8<sup>th</sup> edition of the American Joint Committee on Cancer (AJCC) Tumor, Node, Metastasis (TNM) staging system (2017) for gallbladder cancer distinguishes N1 versus N2 disease by the number of involved nodes (N1, 1 to 3; N2, &gt;3) rather than by the location of involved nodes  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>). It recommends that at least six lymph nodes be removed for proper staging [<a href="#rid7">7</a>]. This change from the 7<sup>th</sup> edition (location-based designation) was based upon studies that demonstrated that the number of metastatic lymph nodes and the lymph node ratio are more prognostic than the location of the metastatic lymph nodes. </p><p class="headingAnchor" id="H367097247"><span class="h2">Hepatic resection</span><span class="headingEndMark"> — </span>For patients with tumors of the fundus or body of the gallbladder, the tumor is generally far enough from the inflow structures to the liver to allow a margin-negative resection with an at least 2 cm nonanatomic wedge resection of the gallbladder fossa or anatomic resection of segments IVb and V  (<a class="graphic graphic_figure graphicRef52260" href="/z/d/graphic/52260.html" rel="external">figure 5</a>) [<a href="#rid126">126</a>]. Various resection margins have been proposed, ranging from 1 to 5 cm, and none are solidly based on carefully collected data [<a href="#rid127">127</a>]. There are no data from randomized trials showing a benefit for anatomic resection of segments IVb and V in patients with localized disease where a negative margin has otherwise been obtained [<a href="#rid128">128</a>]. Although a nonanatomic resection may provide a sufficient margin, an anatomic approach reduces the risk for bleeding or bile leakage [<a href="#rid129">129</a>]. The pattern of drainage of the gallbladder veins may provide support for anatomic IVb/V resection over nonanatomic resection. Veins from the gallbladder rarely enter the portal vein; rather, they drain into the middle hepatic vein via the cholecysto-hepatic veins [<a href="#rid97">97,130</a>]. Direct lymphatic drainage into the liver has also been demonstrated. (See <a class="local">'Lymphatic drainage'</a> above.)</p><p>While a minimal parenchymal resection necessary for clear margins is appropriate in most cases, more aggressive surgical management may occasionally be necessary, which includes resection of other segments of the liver beyond that included in extended cholecystectomy [<a href="#rid131">131,132</a>]. As an example, extended right hepatectomy may be necessary for tumor infiltration into segments IV, V, and VIII or the right portal hilum. </p><p>However, in a series of 104 patients treated at Memorial Sloan-Kettering over a 12 year period, major hepatectomy, resection of adjacent organs other than the liver, and common bile duct excision increased perioperative morbidity but were not associated with better survival [<a href="#rid38">38</a>]. The authors concluded that major hepatic resection (including excision of the common bile duct) was appropriate, when necessary, to clear disease, but not mandatory in all cases. </p><p>Techniques for hepatic resection are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15094.html" rel="external">"Overview of hepatic resection"</a> and  <a class="medical medical_review" href="/z/d/html/88319.html" rel="external">"Open hepatic resection techniques", section on 'Specific resections'</a>.)</p><p class="headingAnchor" id="H90813616"><span class="h2">Laparoscopic port site resection</span><span class="headingEndMark"> — </span>Although available data suggest that laparoscopic manipulation does not diminish the survival of patients with incidentally found gallbladder cancer, port site recurrences have been described [<a href="#rid89">89,133-136</a>]. Although some have recommended port site excision at the time of re-exploration after laparoscopic cholecystectomy [<a href="#rid43">43,78</a>], radical resection does not require resection of the previous laparoscopy port sites [<a href="#rid30">30,136</a>]. If tumor is found in the port sites, this is a marker for disseminated peritoneal disease, and removal of the port sites will not be curative or beneficial [<a href="#rid137">137</a>]. </p><p>In a study of 113 patients with gallbladder cancer detected incidentally at laparoscopic cholecystectomy, 69 had port site resection at the time of re-exploration and 44 did not [<a href="#rid136">136</a>]. Port site disease was seen only in patients with T2 or T3 disease and correlated with the development of peritoneal metastases. Port site resection was not associated with overall survival or recurrence-free survival. Therefore, we do not recommend routine port site resections.</p><p class="headingAnchor" id="H1228877466"><span class="h1">PALLIATIVE PROCEDURES</span><span class="headingEndMark"> — </span>Patients with unresectable gallbladder cancer may develop jaundice, upper abdominal pain, and symptoms of biliary obstruction. The optimal palliative therapy provides relief of symptoms with minimal perioperative morbidity and mortality [<a href="#rid100">100</a>]. The choice of palliative procedure depends upon the nature of obstructive symptoms and an assessment of medical risk associated with the procedure in the context of predicted patient longevity. Available options include: </p><p class="bulletIndent1"><span class="glyph">●</span>Simple cholecystectomy. However, careful judgment must be exercised, recognizing that upper abdominal pain in these instances is rarely a result of cholecystitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endoscopic or percutaneous biliary drainage – (See  <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">"Endoscopic stenting for malignant biliary obstruction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endoscopic stenting or intestinal bypass – (See  <a class="medical medical_review" href="/z/d/html/2676.html" rel="external">"Enteral stents for the palliation of malignant gastroduodenal obstruction"</a> and  <a class="medical medical_review" href="/z/d/html/89300.html" rel="external">"Management of small bowel obstruction in adults"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biliary bypass – Another option in patients who can tolerate surgery is biliary bypass, but many patients fail these procedures with recurrent obstruction as the disease progresses. In one study, intrahepatic segment III cholangiojejunostomy and staying away from the hepatoduodenal ligament, the most common site of disease progression, successfully palliated the majority of patients [<a href="#rid36">36</a>]. </p><p></p><p class="headingAnchor" id="H111057050"><span class="h1">OUTCOMES</span></p><p class="headingAnchor" id="H880750123"><span class="h2">Survival</span><span class="headingEndMark"> — </span>The overall five-year survival for all patients with gallbladder cancer is 20 percent, whereas for patients with localized cancer who are amenable to surgical resection, overall survival reaches 65 percent at five years. </p><p>The nonspecific symptoms and advanced stage of disease at presentation are reflected in the poor outcomes reported in most series for gallbladder cancer. Five-year survival rates are 5 to 12 percent in many large series [<a href="#rid62">62,138,139</a>]. Long-term outcomes are relatively poor for any stage of disease beyond T1N0  (<a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>). Unfortunately, fewer than 10 percent of patients who present with symptoms have T1 tumors [<a href="#rid140">140,141</a>], whereas approximately 20 percent of patients with incidentally diagnosed gallbladder have T1 tumors  (<a class="graphic graphic_table graphicRef71493" href="/z/d/graphic/71493.html" rel="external">table 3</a>) [<a href="#rid9">9</a>]. </p><p>Long-term prognosis, recurrence, and adjuvant therapy for the treatment of gallbladder cancer are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2525.html" rel="external">"Prognosis and adjuvant treatment for localized, resected gallbladder cancer", section on 'Prognosis and patterns of spread'</a> and  <a class="medical medical_review" href="/z/d/html/2525.html" rel="external">"Prognosis and adjuvant treatment for localized, resected gallbladder cancer", section on 'Adjuvant therapy'</a>.)</p><p class="headingAnchor" id="H971879"><span class="h2">Perioperative mortality and morbidities</span><span class="headingEndMark"> — </span>Perioperative mortality rates of gallbladder cancer resection range from 0 to 21 percent [<a href="#rid11">11,33,49,62,63,65,142-146</a>]. Mortality is significantly higher for patients having extensive hepatectomy (right or left hepatectomy, or extended hepatectomy) compared with those having partial hepatectomy (wedge resection) or cholecystectomy (16 versus 2 and 7 percent, respectively) [<a href="#rid147">147</a>]. </p><p>Major morbidity rates of gallbladder cancer resection range from 5 to 54 percent [<a href="#rid11">11,33,34,142</a>]. The most common complications are the same as for other hepatobiliary surgeries, such as postoperative bleeding, bile leak, and perihepatic abscess. (See  <a class="medical medical_review" href="/z/d/html/15094.html" rel="external">"Overview of hepatic resection", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/15094.html" rel="external">"Overview of hepatic resection", section on 'Mortality'</a>.)</p><p class="headingAnchor" id="H8605623"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/83153.html" rel="external">"Patient education: Gallbladder cancer (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H111053273"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staging</strong> <strong>of gallbladder cancer</strong> – Staging prior to considering resection or reresection is important and can be accomplished using a combination of cross-sectional imaging (abdominal CT and MRI with contrast, and chest CT with or without contrast) and diagnostic laparoscopy (for &gt;pT1b patients) to rule out locally unresectable or metastatic disease. The routine use of positron emission tomography (PET) scan or PET/CT in the preoperative setting is controversial, but it may be considered when CT/MRI findings are equivocal. (See <a class="local">'Staging'</a> above and <a class="local">'Evaluation for resectability and staging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for resectability</strong> – Gallbladder cancers with liver or peritoneal metastases, malignant ascites, metastases to lymph nodes beyond locoregional nodes (cystic, common bile duct, hepatic artery, or portal vein), extensive involvement of the hepatoduodenal ligament, or encasement or occlusion of major vessels are not resectable. Such patients should receive palliative chemotherapy and/or radiation therapy. Preoperative jaundice is considered a relative contraindication to radical resection of fundus- but not perihilar-based gallbladder cancer; such patients should undergo multidisciplinary evaluation before surgery is offered. Biliary obstructions can be treated with endoscopic or surgical drainage procedures. Routine use of neoadjuvant therapy to treat locally advanced but nonmetastatic gallbladder cancer is not yet supported by data. (See <a class="local">'Unresectable disease'</a> above and <a class="local">'Palliative procedures'</a> above and  <a class="medical medical_review" href="/z/d/html/2499.html" rel="external">"Treatment of advanced, unresectable gallbladder cancer"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical resection of gallbladder cancer</strong> – Patients with a preoperative diagnosis of potentially resectable, localized gallbladder cancer should be offered definitive resection, which involves en bloc resection of the gallbladder with at least a 2 cm margin of underlying liver bed (nonanatomic resection or anatomic resection of segments IVb and V), portal and hepatoduodenal lymphadenectomy, and possibly extrahepatic bile duct resection. For locally advanced tumors (T3/4), en bloc resection of adjacent organ(s) (eg, duodenum, colon, pancreas) may be required  (<a class="graphic graphic_algorithm graphicRef116505" href="/z/d/graphic/116505.html" rel="external">algorithm 1</a>). (See <a class="local">'Resectable disease'</a> above and <a class="local">'Extended cholecystectomy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gallbladder cancer diagnosed during cholecystectomy</strong> – If an obviously malignant lesion is encountered intraoperatively during laparoscopic cholecystectomy, it is best not to sample the lesion laparoscopically, to reduce the hazard of seeding. Surgeons experienced in complex hepatobiliary surgery may proceed with resection in the same fashion as for a preoperatively diagnosed gallbladder cancer; surgeons less experienced in complex hepatobiliary surgery should close the incision with or without a simple cholecystectomy and refer the patient to an experienced center. (See <a class="local">'Gallbladder cancer diagnosed during gallbladder surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gallbladder cancer diagnosed after cholecystectomy</strong> – For patients with a final diagnosis of T1b, T2, or T3 gallbladder cancer previously unsuspected at the time of cholecystectomy, we suggest surgical reresection rather than other treatments (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). For such patients, reresection entails removing at least a 2 cm margin of the underlying liver bed (nonanatomic resection or anatomic resection of segments IVb and V), portal and hepatoduodenal lymphadenectomy, and possibly extrahepatic bile duct resection  (<a class="graphic graphic_algorithm graphicRef116506" href="/z/d/graphic/116506.html" rel="external">algorithm 2</a> and <a class="graphic graphic_table graphicRef110890" href="/z/d/graphic/110890.html" rel="external">table 1</a>). T1aN0M0 disease is presumed cured by simple cholecystectomy alone and does not require reresection. We do not routinely excise previous laparoscopic port sites at re-exploration. (See <a class="local">'Gallbladder cancer diagnosed after gallbladder surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of bile duct resection</strong> – Extrahepatic bile duct resection should be performed if gross tumor extends into the common bile duct or if frozen section analysis of the cystic duct margin shows tumor involvement. However, we do not advocate routine bile duct resection for the purpose of increasing lymph node yield. (See <a class="local">'Bile duct resection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of lymphadenectomy</strong> – Lymph node dissection is indicated for gallbladder cancers that are &gt;T1a. A proper regional lymph node dissection for gallbladder cancer involves removing all lymph nodes in the porta hepatis and along the hepatoduodenal ligament, including those of the cystic duct, common bile duct, hepatic artery, and portal vein. If an extrahepatic bile duct resection is performed, a regional lymphadenectomy is usually performed with it. In patients who do not require bile duct resection, a portal and hepatoduodenal lymphadenectomy should be performed separately. A minimum of <strong>six</strong> lymph nodes should be removed for proper staging of gallbladder cancer; involvement of lymph nodes beyond the hepatoduodenal ligament is considered distant metastases (M1). (See <a class="local">'Lymph node dissection'</a> above.)</p><p></p><p class="headingAnchor" id="H3200657771"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Richard Swanson, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sharma A, Sharma KL, Gupta A, et al. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol 2017; 23:3978.</a></li><li><a class="nounderline abstract_t">Pilgrim CH, Usatoff V, Evans P. Consideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma. Eur J Surg Oncol 2009; 35:1131.</a></li><li><a class="nounderline abstract_t">Shirai Y, Yoshida K, Tsukada K, et al. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg 1992; 79:659.</a></li><li><a class="nounderline abstract_t">Uesaka K, Yasui K, Morimoto T, et al. Visualization of routes of lymphatic drainage of the gallbladder with a carbon particle suspension. J Am Coll Surg 1996; 183:345.</a></li><li><a class="nounderline abstract_t">Ito M, Mishima Y, Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat 1991; 13:89.</a></li><li><a class="nounderline abstract_t">Terazawa T, Miyake H, Kurahashi M, Tashiro S. Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig. J Med Invest 2004; 51:210.</a></li><li class="breakAll">Zhu AX, Pawlik TM, Kooby DA, et al. Gallbladder. In: AJCC Cancer Staging Manual, 8th ed, Amin MB (Ed), Springer 2017. p.303.</li><li><a class="nounderline abstract_t">Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000; 232:557.</a></li><li><a class="nounderline abstract_t">Goetze TO, Paolucci V. Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry. Ann Surg 2008; 247:104.</a></li><li><a class="nounderline abstract_t">Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996; 120:816.</a></li><li><a class="nounderline abstract_t">Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 1996; 224:639.</a></li><li><a class="nounderline abstract_t">de Aretxabala X, Roa I, Burgos L, et al. Gallbladder cancer in Chile. A report on 54 potentially resectable tumors. Cancer 1992; 69:60.</a></li><li><a class="nounderline abstract_t">Fong Y, Heffernan N, Blumgart LH. Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial. Cancer 1998; 83:423.</a></li><li><a class="nounderline abstract_t">Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg 2007; 11:1188.</a></li><li><a class="nounderline abstract_t">Agarwal AK, Kalayarasan R, Javed A, et al. The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Ann Surg 2013; 258:318.</a></li><li><a class="nounderline abstract_t">Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 2008; 98:485.</a></li><li><a class="nounderline abstract_t">Löhe F, Meimarakis G, Schauer C, et al. The time of diagnosis impacts surgical management but not the outcome of patients with gallbladder carcinoma. Eur J Med Res 2009; 14:345.</a></li><li><a class="nounderline abstract_t">Aloia TA, Járufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford) 2015; 17:681.</a></li><li><a class="nounderline abstract_t">Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 2008; 206:57.</a></li><li><a class="nounderline abstract_t">Shih SP, Schulick RD, Cameron JL, et al. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 2007; 245:893.</a></li><li><a class="nounderline abstract_t">Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 2002; 235:392.</a></li><li><a class="nounderline abstract_t">Butte JM, Gönen M, Allen PJ, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford) 2011; 13:463.</a></li><li><a class="nounderline abstract_t">Gaujoux S, Allen PJ. Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. World J Gastrointest Surg 2010; 2:283.</a></li><li><a class="nounderline abstract_t">Shoup M, Fong Y. Surgical indications and extent of resection in gallbladder cancer. Surg Oncol Clin N Am 2002; 11:985.</a></li><li><a class="nounderline abstract_t">Regimbeau JM, Fuks D, Bachellier P, et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol 2011; 37:505.</a></li><li><a class="nounderline abstract_t">Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg 2011; 253:953.</a></li><li><a class="nounderline abstract_t">Dasari BVM, Ionescu MI, Pawlik TM, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol 2018; 118:477.</a></li><li><a class="nounderline abstract_t">Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 2004; 11:310.</a></li><li><a class="nounderline abstract_t">Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review. Eur J Surg Oncol 2019; 45:83.</a></li><li><a class="nounderline abstract_t">Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am 2010; 39:331.</a></li><li><a class="nounderline abstract_t">Hickman L, Contreras C. Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am 2019; 99:337.</a></li><li><a class="nounderline abstract_t">Foster JM, Hoshi H, Gibbs JF, et al. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol 2007; 14:833.</a></li><li><a class="nounderline abstract_t">Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg 1992; 163:239.</a></li><li><a class="nounderline abstract_t">Ogura Y, Mizumoto R, Isaji S, et al. Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg 1991; 15:337.</a></li><li><a class="nounderline abstract_t">Dixon E, Vollmer CM Jr, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 2005; 241:385.</a></li><li><a class="nounderline abstract_t">Kapoor VK, Pradeep R, Haribhakti SP, et al. Intrahepatic segment III cholangiojejunostomy in advanced carcinoma of the gallbladder. Br J Surg 1996; 83:1709.</a></li><li><a class="nounderline abstract_t">Tashiro S, Konno T, Mochinaga M, et al. Treatment of carcinoma of the gallbladder in Japan. Jpn J Surg 1982; 12:98.</a></li><li><a class="nounderline abstract_t">D'Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 2009; 16:806.</a></li><li><a class="nounderline abstract_t">Sikora SS, Singh RK. Surgical strategies in patients with gallbladder cancer: nihilism to optimism. J Surg Oncol 2006; 93:670.</a></li><li><a class="nounderline abstract_t">Costi R, Violi V, Roncoroni L, Sarli L. Gallbladder cancer and radical surgery. Ann Surg 2008; 248:494; author reply 495.</a></li><li><a class="nounderline abstract_t">Donohue JH, Nagorney DM, Grant CS, et al. Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg 1990; 125:237.</a></li><li><a class="nounderline abstract_t">Sternby Eilard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer - a systematic literature review. Scand J Gastroenterol 2017; 52:505.</a></li><li><a class="nounderline abstract_t">Yamaguchi K, Chijiiwa K, Ichimiya H, et al. Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg 1996; 131:981.</a></li><li><a class="nounderline abstract_t">Shirai Y, Yoshida K, Tsukada K, Muto T. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 1992; 215:326.</a></li><li><a class="nounderline abstract_t">de Aretxabala XA, Roa IS, Burgos LA, et al. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 1997; 163:419.</a></li><li><a class="nounderline abstract_t">Shirai Y, Yoshida K, Tsukada K, et al. Early carcinoma of the gallbladder. Eur J Surg 1992; 158:545.</a></li><li><a class="nounderline abstract_t">Wakai T, Shirai Y, Yokoyama N, et al. Early gallbladder carcinoma does not warrant radical resection. Br J Surg 2001; 88:675.</a></li><li><a class="nounderline abstract_t">Yamaguchi K, Tsuneyoshi M. Subclinical gallbladder carcinoma. Am J Surg 1992; 163:382.</a></li><li><a class="nounderline abstract_t">Ouchi K, Suzuki M, Tominaga T, et al. Survival after surgery for cancer of the gallbladder. Br J Surg 1994; 81:1655.</a></li><li><a class="nounderline abstract_t">Abramson MA, Pandharipande P, Ruan D, et al. Radical resection for T1b gallbladder cancer: a decision analysis. HPB (Oxford) 2009; 11:656.</a></li><li><a class="nounderline abstract_t">Vo E, Curley SA, Chai CY, et al. National Failure of Surgical Staging for T1b Gallbladder Cancer. Ann Surg Oncol 2019; 26:604.</a></li><li><a class="nounderline abstract_t">Coburn NG, Cleary SP, Tan JC, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg 2008; 207:371.</a></li><li><a class="nounderline abstract_t">Wright BE, Lee CC, Iddings DM, et al. Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations? Am J Surg 2007; 194:820.</a></li><li><a class="nounderline abstract_t">Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study. Surgery 2017; 162:515.</a></li><li><a class="nounderline abstract_t">Kwon W, Kim H, Han Y, et al. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. Br J Surg 2020; 107:1334.</a></li><li><a class="nounderline abstract_t">Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 2007; 11:1478.</a></li><li><a class="nounderline abstract_t">Shimada H, Endo I, Togo S, et al. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 1997; 79:892.</a></li><li><a class="nounderline abstract_t">Kapoor VK. Incidental gallbladder cancer. Am J Gastroenterol 2001; 96:627.</a></li><li><a class="nounderline abstract_t">Maithel SK. Optimal surgical management of T2 gallbladder cancer-wedge resection. Surgery 2021; 169:1312.</a></li><li><a class="nounderline abstract_t">Serrablo A, Tejedor L, Torres OJ. Optimal surgical management for T2 gallbladder cancer-formal 4b-5 resection. Surgery 2021; 169:1314.</a></li><li><a class="nounderline abstract_t">Chen M, Cao J, Xiang Y, et al. Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study. Surgery 2021; 169:1304.</a></li><li><a class="nounderline abstract_t">Cubertafond P, Mathonnet M, Gainant A, Launois B. Radical surgery for gallbladder cancer. Results of the French Surgical Association Survey. Hepatogastroenterology 1999; 46:1567.</a></li><li><a class="nounderline abstract_t">Gall FP, Köckerling F, Scheele J, et al. Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg 1991; 15:328.</a></li><li><a class="nounderline abstract_t">Yamamoto M, Onoyama H, Ajiki T, et al. Surgical results of operations for carcinoma of the gallbladder. Hepatogastroenterology 1999; 46:1552.</a></li><li><a class="nounderline abstract_t">Nimura Y, Hayakawa N, Kamiya J, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology 1991; 38:170.</a></li><li><a class="nounderline abstract_t">Benoist S, Panis Y, Fagniez PL. Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg 1998; 175:118.</a></li><li><a class="nounderline abstract_t">Nakamura S, Suzuki S, Konno H, et al. Outcome of extensive surgery for TNM stage IV carcinoma of the gallbladder. Hepatogastroenterology 1999; 46:2138.</a></li><li><a class="nounderline abstract_t">Kayahara M, Nagakawa T. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer 2007; 110:572.</a></li><li><a class="nounderline abstract_t">Mizuno T, Ebata T, Yokoyama Y, et al. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. Br J Surg 2019; 106:626.</a></li><li><a class="nounderline abstract_t">Chijiiwa K, Noshiro H, Nakano K, et al. Role of surgery for gallbladder carcinoma with special reference to lymph node metastasis and stage using western and Japanese classification systems. World J Surg 2000; 24:1271.</a></li><li><a class="nounderline abstract_t">Muszynska C, Nilsson J, Lundgren L, et al. A risk score model to predict incidental gallbladder cancer in patients scheduled for cholecystectomy. Am J Surg 2020; 220:741.</a></li><li><a class="nounderline abstract_t">Konstantinidis IT, Deshpande V, Genevay M, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 2009; 144:441.</a></li><li><a class="nounderline abstract_t">Varshney S, Butturini G, Gupta R. Incidental carcinoma of the gallbladder. Eur J Surg Oncol 2002; 28:4.</a></li><li><a class="nounderline abstract_t">Cavallaro A, Piccolo G, Panebianco V, et al. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol 2012; 18:4019.</a></li><li><a class="nounderline abstract_t">Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol 2008; 34:306.</a></li><li><a class="nounderline abstract_t">A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club. N Engl J Med 1991; 324:1073.</a></li><li><a class="nounderline abstract_t">Antonakis P, Alexakis N, Mylonaki D, et al. Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy. Eur J Surg Oncol 2003; 29:358.</a></li><li><a class="nounderline abstract_t">Giuliante F, Ardito F, Vellone M, et al. Port-sites excision for gallbladder cancer incidentally found after laparoscopic cholecystectomy. Am J Surg 2006; 191:114.</a></li><li><a class="nounderline abstract_t">Cherkassky L, D'Angelica M. Gallbladder Cancer: Managing the Incidental Diagnosis. Surg Oncol Clin N Am 2019; 28:619.</a></li><li><a class="nounderline abstract_t">Lundgren L, Muszynska C, Ros A, et al. Management of incidental gallbladder cancer in a national cohort. Br J Surg 2019; 106:1216.</a></li><li><a class="nounderline abstract_t">Ouchi K, Mikuni J, Kakugawa Y, Organizing Committee, The 30th Annual Congress of the Japanese Society of Biliary Surgery. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg 2002; 9:256.</a></li><li><a class="nounderline abstract_t">Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 Study Group. World J Surg 2011; 35:1887.</a></li><li><a class="nounderline abstract_t">Goetze TO, Paolucci V. Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc 2010; 24:2156.</a></li><li><a class="nounderline abstract_t">Hari DM, Howard JH, Leung AM, et al. A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB (Oxford) 2013; 15:40.</a></li><li><a class="nounderline abstract_t">Ethun CG, Postlewait LM, Le N, et al. A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 2017; 24:1343.</a></li><li><a class="nounderline abstract_t">Creasy JM, Goldman DA, Gonen M, et al. Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies. J Gastrointest Surg 2017; 21:1254.</a></li><li><a class="nounderline abstract_t">Wakai T, Shirai Y, Hatakeyama K. Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy. World J Surg 2002; 26:867.</a></li><li><a class="nounderline abstract_t">Ethun CG, Postlewait LM, Le N, et al. Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium. JAMA Surg 2017; 152:143.</a></li><li><a class="nounderline abstract_t">Suzuki K, Kimura T, Ogawa H. Long-term prognosis of gallbladder cancer diagnosed after laparoscopic cholecystectomy. Surg Endosc 2000; 14:712.</a></li><li><a class="nounderline abstract_t">Sun CD, Zhang BY, Wu LQ, Lee WJ. Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer. J Surg Oncol 2005; 91:253.</a></li><li><a class="nounderline abstract_t">Yoshida T, Matsumoto T, Sasaki A, et al. Laparoscopic cholecystectomy in the treatment of patients with gall bladder cancer. J Am Coll Surg 2000; 191:158.</a></li><li><a class="nounderline abstract_t">Yildirim E, Celen O, Gulben K, Berberoglu U. The surgical management of incidental gallbladder carcinoma. Eur J Surg Oncol 2005; 31:45.</a></li><li><a class="nounderline abstract_t">Kapoor VK, Haribhakti SP. Extended cholecystectomy for carcinoma of the gall bladder. Trop Gastroenterol 1995; 16:74.</a></li><li><a class="nounderline abstract_t">Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg 2004; 8:83.</a></li><li><a class="nounderline abstract_t">You DD, Lee HG, Paik KY, et al. What is an adequate extent of resection for T1 gallbladder cancers? Ann Surg 2008; 247:835.</a></li><li><a class="nounderline abstract_t">Muratore A, Polastri R, Bouzari H, et al. Radical surgery for gallbladder cancer: a worthwhile operation? Eur J Surg Oncol 2000; 26:160.</a></li><li><a class="nounderline abstract_t">Ouchi K, Owada Y, Matsuno S, Sato T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery 1987; 101:731.</a></li><li><a class="nounderline abstract_t">Ouchi K, Suzuki M, Saijo S, et al. Do recent advances in diagnosis and operative management improve the outcome of gallbladder carcinoma? Surgery 1993; 113:324.</a></li><li><a class="nounderline abstract_t">Yokomizo H, Yamane T, Hirata T, et al. Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol 2007; 14:1366.</a></li><li><a class="nounderline abstract_t">Oertli D, Herzog U, Tondelli P. Primary carcinoma of the gallbladder: operative experience during a 16 year period. Eur J Surg 1993; 159:415.</a></li><li><a class="nounderline abstract_t">Paquet KJ. Appraisal of surgical resection of gallbladder carcinoma with special reference to hepatic resection. J Hepatobiliary Pancreat Surg 1998; 5:200.</a></li><li><a class="nounderline abstract_t">Chijiiwa K, Nakano K, Ueda J, et al. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg 2001; 192:600.</a></li><li><a class="nounderline abstract_t">Toyonaga T, Chijiiwa K, Nakano K, et al. Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg 2003; 27:266.</a></li><li><a class="nounderline abstract_t">de Savornin Lohman EAJ, van der Geest LG, de Bitter TJJ, et al. Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease. Ann Surg Oncol 2020; 27:1132.</a></li><li><a class="nounderline abstract_t">Downing SR, Cadogan KA, Ortega G, et al. Early-stage gallbladder cancer in the Surveillance, Epidemiology, and End Results database: effect of extended surgical resection. Arch Surg 2011; 146:734.</a></li><li><a class="nounderline abstract_t">Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 2011; 254:320.</a></li><li><a class="nounderline abstract_t">Matthews JB. Planned laparoscopic approach for early-stage gallbladder cancer: the glass is one-third full. Arch Surg 2010; 145:133.</a></li><li><a class="nounderline abstract_t">Weiland ST, Mahvi DM, Niederhuber JE, et al. Should suspected early gallbladder cancer be treated laparoscopically? J Gastrointest Surg 2002; 6:50.</a></li><li><a class="nounderline abstract_t">Ricardo AE, Feig BW, Ellis LM, et al. Gallbladder cancer and trocar site recurrences. Am J Surg 1997; 174:619.</a></li><li><a class="nounderline abstract_t">Wullstein C, Woeste G, Barkhausen S, et al. Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer? Surg Endosc 2002; 16:828.</a></li><li><a class="nounderline abstract_t">Reddy YP, Sheridan WG. Port-site metastasis following laparoscopic cholecystectomy: a review of the literature and a case report. Eur J Surg Oncol 2000; 26:95.</a></li><li><a class="nounderline abstract_t">Cho JY, Han HS, Yoon YS, et al. Laparoscopic approach for suspected early-stage gallbladder carcinoma. Arch Surg 2010; 145:128.</a></li><li><a class="nounderline abstract_t">Byun Y, Choi YJ, Kang JS, et al. Robotic extended cholecystectomy in gallbladder cancer. Surg Endosc 2020; 34:3256.</a></li><li><a class="nounderline abstract_t">Bloechle C, Izbicki JR, Passlick B, et al. Is radical surgery in locally advanced gallbladder carcinoma justified? Am J Gastroenterol 1995; 90:2195.</a></li><li><a class="nounderline abstract_t">Todoroki T, Kawamoto T, Takahashi H, et al. Treatment of gallbladder cancer by radical resection. Br J Surg 1999; 86:622.</a></li><li><a class="nounderline abstract_t">Behari A, Sikora SS, Wagholikar GD, et al. Longterm survival after extended resections in patients with gallbladder cancer. J Am Coll Surg 2003; 196:82.</a></li><li><a class="nounderline abstract_t">Yamaguchi K, Chijiiwa K, Saiki S, et al. Reliability of frozen section diagnosis of gallbladder tumor for detecting carcinoma and depth of its invasion. J Surg Oncol 1997; 65:132.</a></li><li><a class="nounderline abstract_t">Vega EA, De Aretxabala X, Qiao W, et al. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg 2020; 107:289.</a></li><li><a class="nounderline abstract_t">Kone LB, Bystrom PV, Maker AV. Robotic Surgery for Biliary Tract Cancer. Cancers (Basel) 2022; 14.</a></li><li><a class="nounderline abstract_t">Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4:167.</a></li><li><a class="nounderline abstract_t">Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery 2004; 136:1012.</a></li><li><a class="nounderline abstract_t">Kosuge T, Sano K, Shimada K, et al. Should the bile duct be preserved or removed in radical surgery for gallbladder cancer? Hepatogastroenterology 1999; 46:2133.</a></li><li><a class="nounderline abstract_t">Chijiiwa K, Tanaka M. Indications for and limitations of extended cholecystectomy in the treatment of carcinoma of the gall bladder. Eur J Surg 1996; 162:211.</a></li><li><a class="nounderline abstract_t">Muratore A, Polastri R, Capussotti L. Radical surgery for gallbladder cancer: current options. Eur J Surg Oncol 2000; 26:438.</a></li><li><a class="nounderline abstract_t">Birnbaum DJ, Viganò L, Russolillo N, et al. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol 2015; 22:811.</a></li><li class="breakAll">Blumgart LH. Surgery of the Liver, Biliary Tract and Pancreas, 4th ed, Saunders, Philadelphia 2007.</li><li><a class="nounderline abstract_t">Endo I, Shimada H, Takimoto A, et al. Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma. World J Surg 2004; 28:692.</a></li><li><a class="nounderline abstract_t">Sicklick JK, Choti MA. Controversies in the surgical management of cholangiocarcinoma and gallbladder cancer. Semin Oncol 2005; 32:S112.</a></li><li><a class="nounderline abstract_t">Scheingraber S, Justinger C, Stremovskaia T, et al. The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol 2007; 5:55.</a></li><li><a class="nounderline abstract_t">Misra MC, Guleria S. Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J Surg Oncol 2006; 93:690.</a></li><li><a class="nounderline abstract_t">Shimada K, Nara S, Esaki M, et al. Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg 2011; 98:117.</a></li><li><a class="nounderline abstract_t">Reddy SK, Marroquin CE, Kuo PC, et al. Extended hepatic resection for gallbladder cancer. Am J Surg 2007; 194:355.</a></li><li><a class="nounderline abstract_t">Steinert R, Nestler G, Sagynaliev E, et al. Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol 2006; 93:682.</a></li><li><a class="nounderline abstract_t">Whalen GF, Bird I, Tanski W, et al. Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg 2001; 192:189.</a></li><li><a class="nounderline abstract_t">Lundberg O, Kristoffersson A. Port site metastases from gallbladder cancer after laparoscopic cholecystectomy. Results of a Swedish survey and review of published reports. Eur J Surg 1999; 165:215.</a></li><li><a class="nounderline abstract_t">Maker AV, Butte JM, Oxenberg J, et al. Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol 2012; 19:409.</a></li><li><a class="nounderline abstract_t">Berger-Richardson D, Chesney TR, Englesakis M, et al. Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review. Surgery 2017; 161:618.</a></li><li><a class="nounderline abstract_t">Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. Aust N Z J Surg 1995; 65:724.</a></li><li><a class="nounderline abstract_t">Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75:171.</a></li><li><a class="nounderline abstract_t">Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg 2006; 243:767.</a></li><li><a class="nounderline abstract_t">Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients. Ann Surg Oncol 2007; 14:827.</a></li><li><a class="nounderline abstract_t">Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery 1989; 106:467.</a></li><li><a class="nounderline abstract_t">Butte JM, Matsuo K, Gönen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg 2011; 212:50.</a></li><li><a class="nounderline abstract_t">Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery 2002; 132:555.</a></li><li><a class="nounderline abstract_t">Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg 1994; 219:275.</a></li><li><a class="nounderline abstract_t">Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003; 98:1689.</a></li><li><a class="nounderline abstract_t">Jin LX, Pitt SC, Hall BL, Pitt HA. Aggressive surgical management of gallbladder cancer: at what cost? Surgery 2013; 154:266.</a></li></ol></div><div id="topicVersionRevision">Topic 15097 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28652652" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19297118" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Consideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1643479" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Identification of the regional lymphatic system of the gallbladder by vital staining.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8843263" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Visualization of routes of lymphatic drainage of the gallbladder with a carbon particle suspension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1925922" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : An anatomical study of the lymphatic drainage of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15460908" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15460908" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10998654" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18156929" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8909516" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8916879" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Long-term results after resection for gallbladder cancer. Implications for staging and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1727676" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Gallbladder cancer in Chile. A report on 54 potentially resectable tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9690533" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17712596" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Surgical management of gallbladder carcinoma: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23059504" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18802958" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19666394" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The time of diagnosis impacts surgical management but not the outcome of patients with gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26172135" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Gallbladder cancer: expert consensus statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18155569" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17522515" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Gallbladder cancer: the role of laparoscopy and radical resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11882761" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21689230" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The role of laparoscopic staging in patients with incidental gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21160897" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12607584" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Surgical indications and extent of resection in gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21514090" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21490453" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Gallbladder cancer involving the extrahepatic bile duct is worthy of resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30259519" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14993027" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30287098" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20478489" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Management of gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30846038" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17103074" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1739180" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1853612" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Radical operations for carcinoma of the gallbladder: present status in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15729060" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9038546" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Intrahepatic segment III cholangiojejunostomy in advanced carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7109362" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Treatment of carcinoma of the gallbladder in Japan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18985272" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Analysis of the extent of resection for adenocarcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16724356" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Surgical strategies in patients with gallbladder cancer: nihilism to optimism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18791371" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Gallbladder cancer and radical surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2302063" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Carcinoma of the gallbladder. Does radical resection improve outcome?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28270039" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Surgical treatment for gallbladder cancer - a systematic literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8790169" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Gallbladder carcinoma in the era of laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1558412" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9231853" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Curative resection in potentially resectable tumours of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1360827" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Early carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11350438" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Early gallbladder carcinoma does not warrant radical resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1558279" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Subclinical gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7827897" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Survival after surgery for cancer of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20495633" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Radical resection for T1b gallbladder cancer: a decision analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30499077" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : National Failure of Surgical Staging for T1b Gallbladder Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18722943" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Surgery for gallbladder cancer: a population-based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18005778" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28629653" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32452559" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17846848" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9041150" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The role of lymph node dissection in the treatment of gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11280526" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Incidental gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33610342" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Optimal surgical management of T2 gallbladder cancer-wedge resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33685723" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Optimal surgical management for T2 gallbladder cancer-formal 4b-5 resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33551070" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10430296" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Radical surgery for gallbladder cancer. Results of the French Surgical Association Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1853611" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Radical operations for carcinoma of the gallbladder: present status in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10430293" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Surgical results of operations for carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1649788" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9515527" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10521956" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Outcome of extensive surgery for TNM stage IV carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17594719" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30762874" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11071474" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Role of surgery for gallbladder carcinoma with special reference to lymph node metastasis and stage using western and Japanese classification systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32037044" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A risk score model to predict incidental gallbladder cancer in patients scheduled for cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19451486" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11869005" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Incidental carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22912553" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17964753" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1826143" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12711289" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16399118" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Port-sites excision for gallbladder cancer incidentally found after laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31472909" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Gallbladder Cancer: Managing the Incidental Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31259388" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Management of incidental gallbladder cancer in a national cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12140616" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21547420" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Incidental gallbladder cancer by the AFC-GBC-2009 Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20177938" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23216778" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27812827" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28484891" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11960212" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27784058" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10954815" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Long-term prognosis of gallbladder cancer diagnosed after laparoscopic cholecystectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16121343" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10945359" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Laparoscopic cholecystectomy in the treatment of patients with gall bladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15642425" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The surgical management of incidental gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8854963" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Extended cholecystectomy for carcinoma of the gall bladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14746839" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Surgical treatment of gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18438121" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : What is an adequate extent of resection for T1 gallbladder cancers?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10744936" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Radical surgery for gallbladder cancer: a worthwhile operation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2438791" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Prognostic factors in the surgical treatment of gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8441967" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Do recent advances in diagnosis and operative management improve the outcome of gallbladder carcinoma?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17260109" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8218552" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Primary carcinoma of the gallbladder: operative experience during a 16 year period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9745089" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Appraisal of surgical resection of gallbladder carcinoma with special reference to hepatic resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11333097" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12607049" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31741109" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Re-resection in Incidental Gallbladder Cancer: Survival and the Incidence of Residual Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21690451" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Early-stage gallbladder cancer in the Surveillance, Epidemiology, and End Results database: effect of extended surgical resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21617582" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20183936" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Planned laparoscopic approach for early-stage gallbladder cancer: the glass is one-third full.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11986018" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Should suspected early gallbladder cancer be treated laparoscopically?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9409585" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Gallbladder cancer and trocar site recurrences.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11997831" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10718188" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Port-site metastasis following laparoscopic cholecystectomy: a review of the literature and a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20157079" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Laparoscopic approach for suspected early-stage gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32306112" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Robotic extended cholecystectomy in gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8540515" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Is radical surgery in locally advanced gallbladder carcinoma justified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10361182" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Treatment of gallbladder cancer by radical resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12517555" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Longterm survival after extended resections in patients with gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9209526" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Reliability of frozen section diagnosis of gallbladder tumor for detecting carcinoma and depth of its invasion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31873948" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35205792" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Robotic Surgery for Biliary Tract Cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12623362" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15523394" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10521955" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Should the bile duct be preserved or removed in radical surgery for gallbladder cancer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8695736" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Indications for and limitations of extended cholecystectomy in the treatment of carcinoma of the gall bladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11016462" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Radical surgery for gallbladder cancer: current options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25201500" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25201500" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15175901" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16399447" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Controversies in the surgical management of cholangiocarcinoma and gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17517122" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : The standardized surgical approach improves outcome of gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16724357" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Management of cancer gallbladder found as a surprise on a resected gallbladder specimen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21136566" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17693282" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Extended hepatic resection for gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16724350" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Laparoscopic cholecystectomy and gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11220719" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10231654" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Port site metastases from gallbladder cancer after laparoscopic cholecystectomy. Results of a Swedish survey and review of published reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21698501" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Is port site resection necessary in the surgical management of gallbladder cancer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27743715" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7487712" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Carcinoma of the gall-bladder: an experience and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8000995" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Liver, gallbladder, extrahepatic bile ducts, and pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16772780" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17109082" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2772822" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Aggressive surgery for carcinoma of the gallbladder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21075015" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12407338" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Improved survival in resected biliary malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8147608" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14534886" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23830031" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Aggressive surgical management of gallbladder cancer: at what cost?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
